²´¬ì¾ÇºîÄý Ophthalmology
Overview
²Ä2¥U ²Ä3³¹
ºô½¤ÃèÀ˼vªk Retinoscopy
¤ýħ«J
ºô½¤ÃèÀ˼vªk(retinoscopy©Îskiascopy)¡A¬O¹q¸£Åç¥ú(autorefraction)¤§¥~¡A¨Ï¥Î³Ì¦hªº«ÈÆ[Åç¥úªk¡A¥¦¦³³\¦h¹q¸£Åç¥ú©Ò¤£¯à¤ÎªºÀuÂI¡A¬O²´¬ìªù¶E±`³ÆªºÀˬd¤u¨ã¡C
²Ä1¸` ºô½¤ÃèÀ˼vªkªºì²z
1.1 ºô½¤ÃèÀ˼vªk
ºô½¤ÃèÀ˼vªk (¹Ï3
¹Ï3
1.2 ±aª¬ºô½¤Ãè
±aª¬ºô½¤Ãè (streak retinoscope)ªº±aª¬¥ú¥Ñ¥k¦V¥ª²¾°Ê¡AÀû¤Õªº¤Ï¥ú¥i¯à¦P¦V¶¶°Ê(with-movement)¡A¤]¥i¯à¤Ï¦V°f°Ê (against-movement)¡A¦pªGÀû¤Õªº¤Ï¥ú©M±aª¬¥ú·½²¾°Êªº¤è¦VªuµÛ¤£¦Pªº¨«¦V¡Aªí¥Ü¬O¦³±×¦Vªº´²¥ú (¹Ï3-2)¡C
¹Ï3-2 ¶¶°Ê¡B°f°Ê©M±×¦V¹B°Êªº¤Ï¥ú
¯f¤Hªº»·ÂI¡A¥ç§Y¸g¹L²´²yªº¥ú¾Ç¨t²Î¡Aµøºô½¤¦bªÅ¶¡ªº¦@³mÂI (conjugate point)¡A¦pªG¦bÀˬdªÌ¤§«á¡A¬Ý¨ìªº¬O¶¶°Ê¤Ï¥ú¡F¦Ó¤ñ¸ûªñµøªº¤H¡A»·ÂI¸¨¦b¯f¤H©MÀˬdªÌ¤§¶¡¡A«h¬O°f°Ê¤Ï¥ú¡C³v¨B¥[¤J¸ÕÃè¤ù©ó¯f¤H²´«e¡A±N»·ÂI±À²¾¦ÜÀˬdªÌ¨¤½¤ªº¦ì¸m®É¡A¬Ý¨ìªº¬O¤@¤j¤ù¤Ï¥ú¥Rº¡Àû¤Õ¡A³o¬O¤¤©MÂI (neutral point)¡A³o®É¥Ñ©Ò¥[¸ÕÃè¤ùªº«×¼Æ¡A¥i¥Hpºâ¡B§PŪ¥X¯f¤Hªº©}¥ú«×¼Æ (¹Ï3-3)¡C©M¯f¤Hªº¶ZÂ÷¤]«Ü«n¡A¥ª¹Ï©M¯f¤H¶ZÂ÷50cm¡A¥H¸ÕÃè-3D±o¨ì¤¤©MÂI¡A·N§YÀ¹¤F-3Dªº²´Ã褧«á¡A»·ÂI¸¨¦b¯f¤H¤§«e50cm¡A¤]´N¬OÁÙ¦³-2Dªºªñµø¡A©ó¬O³o²´ªº©}¥úȬO-5D (-3D
+ -2D)¡F¦pªG´ú¸Õ¶ZÂ÷¤ñ¸ûªø¡A¦p¥k¹Ï¦b67cm¡A·N«ä¬OÀ¹¤F-3Dªº²´Ã褧«á¡A»·ÂI¸¨¦b¯f¤H¤§«e67cm¡A¤]´N¬OÁÙ¦³-1.5Dªºªñµø¡A©ó¬O³o²´ªº©}¥ú¬O-4.5D (-3D
+ -1.5D)¡C
¹Ï3-3 ¦b¤¤©MÂI¡A¥Ñ(1)¸ÕÃè¤ùªº«×¼Æ©M(2)´ú¸Õ¶ZÂ÷§PŪ¥X¯f¤Hªº©}¥ú«×¼Æ
¹J¨ì±×¦V´²¥ú¡A¤@¶}©l¬Ý¨ìªºÀû¤Õ¤Ï¥úªº¤è¦V¨Ã¤£¬O´²¥úªº¨¤«×¡CnÂà°Êºô½¤Ãè±aª¬¥ú·½ªº¤è¦V¡A½Õ¾ã¨ì©MÀû¤Õ¤Ï¥úªº¤è¦V¤@P¡A³o®ÉÔ±aª¬¥ú·½©MÀû¤Õ¤Ï¥úªº¤è¦V¤~¬O´²¥úªº¨¤«×¡C¯f¤Hªº©}¥ú«×¼Æ¬OnŪ¥X (1)³oÓ¨¤«×©M (2)««ª½©ó³oÓ¨¤«×¨âÓ¤è¦Vªº©}¥úÈ (¹Ï3-4)¡C
¹Ï3-4 ±×¦V´²¥ú¡A(1)§PŪ¨âÓ¤è¦Vªº©}¥úȤÎ(2)¯f¾ú°O¿ý¡C
ºô½¤ÃèÀ˼vªk§xÃø¤§³B¡A¬O¦b¤¤©MÂI©Ò¨£ªºÀû¤Õ¤Ï¥ú¬O¤@¤j¤ùªº¤Ï¥ú¥Rº¡¾ãÓÀû¤Õ¡A¦Ó¦b¤¤©MÂI«e¡B«á0.5DªºÀû¤Õ¤Ï¥ú¬Ý°_¨Ó¤]®t¤£¦h¡A¤]¬O¤@¤j¤ù¤Ï¥ú¡C©ó¬O¥¦¨Ã¤£¹³¬O¤@Ó¤¤©M ¡¨ÂI¡¨¡A¦Ó¹³¬O¤@Ó¤¤©M ¡¨°Ï¡¨ (neutral zone)¡C
ºô½¤ÃèÀ˼vªk©Ò¨£ªº¤Ï¥ú¦n¤ñ¬O¤@¯ë¥Y³zÃ誺¥ú¾Ç¡C¥Y³zÃè¾aªñ¯È±i¨Ó¬Ý¬O©ñ¤jÃè¡A¬Ý¨ìªº¬O¥¿¥ßªºµê¹³¡F¥Y³zÃ讳°_¨Ó¡A³z¹L¥Y³zÃè¬Ý»·¤è¡A«h¬OÁY¤pªºË¥ß¹ê¹³¡C¤¤©MÂI´N¦n¤ñ«e«á²¾°Ê¥Y³zÃè¡A¥h§ä¥X¥¿¹³Åܦ¨Ë¹³ªº¨º¤@ÓÂI¡C¦b³oÓ¤¤©MÂI¡A¥Y³zÃ褤©Ò¨£ªº¬O¡¨¤@ÓÂI¡¨ªº¼v¹³µL½a©ñ¤j¡B¥Rº¡¾ãÓ¥Y³zÃè¡A©ÎªÌ»¡¬OµL½a¤jªº¾î¦V©ñ¤j²v(transverse magnification)¡C¦b50cmªº´ú¸Õ¶ZÂ÷¡A-2D¬O¤¤©MÂI¡A¦Ó¥i¥H¤À¿ë¥X¬O¶¶°Êªº¤Ï¥ú¡B¤Ï¥ú·¥¼e¡B´X¥G§Ö¬Ý¤£¨ì¬O±aª¬¤Ï¥úªº¡A«h¬O-1.25D (¹Ï3-5)¡C-1.5D¡B-1.75D¡B-2DªºÀû¤Õ¤Ï¥ú³£¬O¤@¤j¤ù¥ú¼v¡A¤£®e©ö¤À¿ë¡C§Ú«Øij¥H-1.25D§@¬°ºô½¤ÃèÀ˼vªk§PŪªº¨Ì¾Ú¡A·|¤ñ-2Dn¦n¥Î¡C
¹Ï3-5¥Ñ¥¿µø²´¦Ü-1.25Dªº¶¶°Ê¤Ï¥úªº¼e«×
±aª¬ºô½¤Ã誺±aª¬¥ú·½¬O¿Oªwªº¿Oµ·¸g¹L¤@¤ù¥Y³zÃ誺¦¨¹³ (¹Ï3-6)¡A¥Y³zÃè¬O¥ú¾Ç¨t²Îªº¥ú°é(aperture)¡A¨î¤F±aª¬¥ú·½ªº¼e«×¡Cºô½¤Ãè¤W¦³¤@Ó±Àµ©/±À±ì¡A¤W¤U²¾°Ê·|§ïÅÜ¿Oªw©M¥Y³zÃ趡ªº¶ZÂ÷¡A¦P®É¤]§ïÅÜ¥ú·½ªºµo´²«× (vergence)¡C
¹Ï3-6 ±aª¬ºô½¤Ã誺±aª¬¥ú·½¬O¿Oªwªº¿Oµ·¸g¹L¤@¤ù¥Y³zÃ誺¦¨¹³¡C
¥ú·½¥i¥H±À±ì§ïÅܬ°µo´²(divergent)¥ú©Î»E¦X(convergent)¥ú¡C
¤j³¡¤À¤H²ßºD¨Ï¥Îµo´² (divergent)©Î¥¦æ (parallel)ªº¥ú·½¡C¦pªG¥H¤º»E¥ú·½(convergent
illumination) §@ºô½¤ÃèÀ˼v¡A¤]´N¬O¥ú·½¬O¤º»E¥ú¡A¦bÀˬdªÌ©M¯f¤H¤§¶¡¥ý»EµJ¤F¤@¦¸¡C³o¼Ëªº¸Ü¡A¶¶°Ê¡B°f°Ê¤Ï¥ú·|¬Û¤Ï¹L¨Ó¡G¥Îµo´²/¥¦æ¥ú·½¬Ý¬O¶¶°Ê¤Ï¥úªº©}¥ú«×¡A¥Î¤º»E¥ú·½·|¨£¨ì¬O°f°Êªº¤Ï¥ú¡F¥Îµo´²/¥¦æ¥ú·½¬Ý¬O°f°Ê¤Ï¥úªº©}¥ú«×¡A¥Î¤º»E¥ú·½·|¨£¨ì¬O¶¶°Êªº¤Ï¥ú¡C
²Ä2¸` ºô½¤ÃèÀ˼vªkªºÀ³¥Î
ºô½¤ÃèÀ˼vªkªºÁ{§ÉÀ³¥Î¡A¤À¥®¨à¡B¾Çµ£©M¦¨¤H¤T¤è±¨Ó»¡©ú¡C
2.1 ¥®¨àªººô½¤ÃèÀ˼v
ÁöµM¥Ø«eªº¹q¸£Åç¥ú¾÷¤w¸g«D±`·Ç½T¡A¦ý¬O¨â·³¥H¤Uªº¥®¨à³q±`¨S¦³¿ìªk¦n¦n´N¦ì¡A¨S¦³¿ìªkª`µøµø¼Ð¡A§Y«K¬O¤â«ù¦¡ªºÅç¥ú¾÷¡A¹³Retinomax¡A¨Ì¦³«Ü¤jªº§xÃø¡C³o®ÉÔºô½¤ÃèÀ˼vªk¦¨¤F´ú¶q©}¥úªº°ß¤@¤èªk (¹Ï3-7)¡C¹ï©ó¤@¨Ç¨¤ß»Ùê¡A¤×¨ä¬O´¼»Ùªº¤j«Ä¤l¡A¤]¬O±o¾aºô½¤ÃèÀ˼vªk¥h±o¨ì¥L̪º©}¥úª¬ºA¡C
¹Ï3-7 ºô½¤ÃèÀ˼vªk¬O´ú¶q¥®¨à©}¥úªº°ß¤@¤èªk
ÁaµM¤w¸g¦³¤F´²Àû«áªº©}¥úÈ¡A¦ý¬O¤pªB¤Í¦b¨S´²Àûªº±¡ªp¤U¡A¦³¦h¤Ö¸g±`©Êªº½Õ
µJ©O¡H°tÃ誺®ÉÔ¡A±`±`·|pµe¨â²´»·µø³£§@¤Ö¶qªº¤íÁB¡F¦³®É·|±N¤@²´Ãú¤Æ¾B½ª(optical
penalization)¥HªvÀø®zµø¡K¡CÅç¥ú°tÃ誺³Ì«á¤@¨B¡AÁÙ¬O±o¦b³Ì¦ÛµMªºª¬ªp¤U¡A¤pªB¤ÍÀ¹¤W¸ÕÃè¡Bª`µø»·¤è¡A¥Hºô½¤ÃèÀ˼vªk«Å|Åç¥ú¡A´ú¶q²´·ú¡B²´ÃèÅ|¥[¦b¤@°_ªº«×¼Æ¡A½T»{µL»~¤§«á¡A²´Ãè³B¤è¤~¼g±o¤ß¦w²z±o (¹Ï3-8)¡C
¹Ï3-8 «Å|Åç¥ú°tÃè
¦³¨Ç¥®¨à¶i¨ì¶E¶¡ÀH§Y¤jú¤j¾x¡C¨Ò¦p¤pªB¤Í¤º±×µø¡Aªì¨Bºô½¤ÃèÀ˼vµo²{¬O°ª«×
»·µø¡A¥²»Ýn°tÃè¡A¦ý¬O«oµLªkÀˬd¨ì·Ç½Tªº«×¼Æ¡A³o®ÉÔ´N»Ýn¥H¤ô¦X´âîÇÂíÀR«á¤~¯àÅç¥ú°tÃè (¹Ï3-9)¡C¥®¨à©Î¤£¦X§@ªº¤pªB¤Íªº°ª«×´²¥ú¡B¨â²´¤£µ¥µø¡B°ª«×ªñµø¡KºØºØ±¡ªp¡A¬°¤FªvÀø®zµø¦Ó¥²»Ý°tÃ誺®ÉÔ¡A±`±`±o¥X¦¹¤Uµ¦¡C
¹Ï3-9¤ô¦X´âîÇÂíÀR¤UªºÅç¥ú°tÃè
¤pªB¤Íªº½ÕµJ¤O±j¡A¹q¸£Åç¥úµ²ªG±`±`±o¨ì¹L¦hªºªñµø©ÎªÌ¤£¨¬ªº»·µø¡A§Y«K´²Àû«á¤]¸g±`¦p¦¹¡C±`µo¥Íªº±¡´º¬O¡A»·µø²´ªº¤pªB¤Í¨Ó¶E¡AÀ¹µÛ²´Ãè«Å|Åç¥ú¡Aµo²{¤´¦³+2D¨ì+3Dªº»·µø¡A²´Ãè¤íÁB¹L¦h¡C¦b°÷¤jªº¶E¶¡¡Aª`µø°÷»·ªº¥Ø¼Ðª«¡Aºô½¤ÃèÀ˼vªk¬OÀËÅç¹q¸£Åç¥úªº®ÉÔ¤pªB¤Í¹L«×½ÕµJªº¤@Ó²³æªº¤£¤Gªkªù (¹Ï3-10)¡C
¹Ï3-10 ºô½¤ÃèÀ˼vªkÀËÅç¤p¨à¹q¸£Åç¥ú®Éªº¹L«×½ÕµJ
2.2 ¾Çµ£ªººô½¤ÃèÀ˼v
±q¥¿µø²´¨ìªñµø-1.25D¡A¶È¥ÑÀû¤Õ¤Ï¥úªº¼e«×¡A¤£¥²¥t¥[Ãè¤ù§@«Å|Åç¥ú¡A´N¥i
¥HŪ¥X«×¼Æ¡C¾Çµ£ªñµø³vº¥¥[²`¡A³z¹L²´Ãè§@«Å|Åç¥ú¡A¥ß¨è¥i¥H§i¶D®aªøªñµø¥[²`¤F¦h¤Ö«×¡C³q±`¥[²`1D¥ª¥k«K·|«·s°t»s«×¼Æ¨¬°÷ªº·s²´Ãè¡C¦A¦^¶E®É¡A¤S¥i¥H¶È¥ÑÀû¤Õ¤Ï¥úªº¼e«×¡A§i¶D®aªøªñµø¥[²`¤F¦h¤Ö¡C
¦pªG¾Çµ£ªº²´Ã褣¥u²yÃè«×¼Æ¤£¥¿½T¡A´²¥úªº«×¼Æ©M¨¤«×¤]¦³»~®t¡A¤]¥i¥H³z¹L«
Å|Åç¥ú¨Ó§@·L½Õ (¹Ï3-11)¡C«Å|Åç¥ú©Ò¨£¡A¥k²´¶¶³W´²¥ú¤£¨¬0.5D¡A¨¤«×À³µy¬°°f®ÉÄÁ±ÛÂà¡F¥ª²´»·µø¤íÁB0.5D¡C¥Ñ²´Ãè¥[¤W«Å|Åç¥úªºµ²ªG¡A·s²´Ã誺«×¼Æ´N¤w¸g¤jP´Nºü¡C
¹Ï3-11 ³z¹L«Å|Åç¥ú·L½Õ´²¥úªº«×¼Æ¤Î¨¤«×
2.3 ¦¨¤Hªººô½¤ÃèÀ˼v
¦¨¤H²´·ú¯h³Ò¡A¬Ý¹q¸£²´·úµmÀߨӶE¡A²Ä¤@¨B´N¬OÀËÅç©ÒÀ¹ªº²´Ãè¬O§_ªñµø¹LÁB¡A
³o¬O»á±`µo¥Íªº¨Æ±¡¡C¹q¸£Åç¥ú¤£¤@©w¥i¥Hµo²{°ÝÃD¡A¯f¤Hª`µø»·¤èµø¼Ð¡AÀ¹µÛ²´Ãè§@«Å|Åç¥ú¬Oµo²{°ÝÃD³Ì²³æ¤Sºë½Tªº¤èªk (¹Ï3-12)¡C
¹Ï3-12«Å|Åç¥úµo²{ªñµø²´Ãè¹LÁB
¦¨¤H¹L«×½ÕµJªº±¡ªp¤£¦h¨£¡A°t¦X¥H¼e´¯ªºÀˬd«Ç©M°÷»·ªºª`µøµø¼Ð (¹Ï3-13)¡A
¥i¥Hºô½¤ÃèÀ˼vªkÅç¥ú°tÃè¡A´²ÀûÀˬd³q±`¬O¤£¥²nªº¡C
¹Ï3-13 ¦¨¤Hªººô½¤ÃèÀ˼vªkÅç¥ú°tÃè¡A´²ÀûÀˬd³q±`¬O¤£¥²nªº
ºî¤W©Òz¡Aºë·Ç°tÃè¥i¥H²¤Æ¬°¤TÓ¨BÆJ (¹Ï3-14)
(1) ¹q¸£Åç¥ú±o¨ìªì¨Bªº°Ñ¦Ò
(2) ©ñ¤WÃè¤ù¡Aºô½¤ÃèÀ˼vªk§@«Å|Åç¥ú¡A·L½Õ«×¼Æ©M´²¥ú¨¤«×
(3) ¥H¥DÆ[Åç¥úªk¦A§@½Õ¾ã¡A±o¨ì¥¿½Tªº«×¼Æ¡C
¹Ï3-14 ºë·Ç°tÃ誺¤TÓ¨BÆJ
²Ä3 ¸` ½m²ßºô½¤ÃèÀ˼vªk
3.1 »{ÃÑÀû¤Õ¤Ï¥úªº²Ä¤@¨B
ºô½¤ÃèÀ˼vªk¥u¦³¾Þ§@ªÌ¦Û¤v¤@Ó¤H¬Ý±o¨ìÀû¤Õ¤Ï¥ú¡A¨Ã¨S¦³¹³¶¡±µ²´©³Ã診¼Ëªþ¥[ªº±Ð¾ÇÃèÅý¾Ç¥Í̤@°_Æ[¬Ý¾Ç²ß¡C
¾Ç¥Í¾Ç²ßºô½¤ÃèÀ˼vªk¡AnÅý¥L̪¾¹DÀû¤Õ¤Ï¥ú¤j·§ªº¼Ë¤l¡A³Ì²³æªº¤èªk¬O¥Î§t+10Dªº¨º¤@¤äÀ˼v´Î (retinoscopic rack)¡A±N¥¦©T©w¦b¤@±i¯È«Ì¹õ¤§«e¤j¬ù10¤½¤Àªº¦a¤è (¹Ï3-15)¡C¦b³oÓ¨Ò¤l¸Ì¡A+12D(¬õ¦r)¨º¤@®æ©Ò¨£¬O¥¿µø²´ªºÀû¤Õ¤Ï¥ú¡A©ó¬O+11D¨º®æ©Ò¨£«K¬O+1D»·µø²´ªºÀû¤Õ¤Ï¥ú¡A+13D¨º®æ©Ò¨£«K¬O-1Dªñµø²´ªºÀû¤Õ¤Ï¥ú¡A+14D¨º®æ©Ò¨£«K¬O-2Dªñµø²´ªºÀû¤Õ¤Ï¥ú.¡K¡C
¹Ï3-15 À˼v´Î©T©w¦b¤@±i¯È«Ì¹õ¤§«e¤j¬ù10¤½¤Àªº¦a¤è
3.2 ¥H¼ÒÀÀ²´ (model eye)½m²ßºô½¤ÃèÀ˼vªk
¦A¨Ó´N¬O¥H¼ÒÀÀ²´(model eye/¼ÒÀÀ²´/±Ð¾Ç¥Î½m²ß²´/À˼v½m²ß²´/°²²´)¨Ó½m²ß¤F¡C¥ý§@²yÃè(³æ¯Âªñµø¡B»·µø)ªº½m²ß¡A¼ô½m¡B¥R¤À§â´¤§Þ¥©¤§«á¡A¦A§@¬WÃè(´²¥ú)ªº½m²ß¡C½m²ß¤èªk¦p¤U¡G
(1) ²Ä¤@¨B¡G²yÃè½m²ß
(a) ±N¼ÒÀÀ²´³]¸m¬°¥¿µø²´ (emmetropia)¡C
¼ÒÀÀ²´¨Æ¥ýn°µ®Õ·Ç (¹Ï3-16)¡A¤£¦Pªº¼ÒÀÀ²´¦³¤£¦Pªº°µªk¡G¥ª¹Ï¬OÂà¶}Á³µ·¡B®Õ¥¿·Ç¬P¡F¥k¹Ï«h¬OÂà°ÊÁ³µ·¡A±À«e©Î©Ô«áºô½¤ªº¦ì¸m¡C
¹Ï3-16 ®Õ·Ç¼ÒÀÀ²´
(b) Ãè½c¨ú¥X²yÃè -1D¦Ü-6D¡A+1D¦Ü+6D (³Ì¦n¬O²Óª÷ÄÝÃä®Øªº¸Õ¤ù)¡A¶¡¹j1D¡A¦@12¤ù¡C
(c) ÀH¾÷¥ô·N¿ï¨ú¤G¤ù¸Õ¤ù¸m©ó¼ÒÀÀ²´ªºÃè¼Ñ¡C
(d) ºô½¤ÃèÀ˼vªkŪ¨ú©}¥úÈ¡C
(e) ¬Ýµ²ªG¡A¨Ò¦p¨âÓÃè¤ù¬O-3D©M-6D¡Aºô½¤ÃèÀ˼vÀ³¸ÓŪ¥X+9Dªº©}¥úÈ¡C
(f) ³o12¤ù¸Õ¤ù¥i¥H²Õ¦X¥X-11D¦Ü+11D¡A¶¡¹j¬°1Dªº23ºØ©}¥úÈ¡C
(g) ¶¡¹j1Dªº½m²ß·Ç½T«×¹F¨ì¹s¥¢»~¤§«á¡A½m²ß«×¼Æªº¶¡¹j°§C¬°0.5D¡C
(h) Ãè½c¨ú¥X²yÃè-0.5D¦Ü-6D¡A+0.5D¦Ü+6D¡A¶¡¹j0.5D¡A¦@22¤ù¡C
(i) ÀH¾÷¥ô·N¿ï¨ú¤G¤ù¸Õ¤ù¸m©ó¼ÒÀÀ²´ªºÃè¼Ñ¡C
(j) ºô½¤ÃèÀ˼vªkŪ¨ú©}¥úÈ¡C
(k) ¬Ýµ²ªG¡A¨Ò¦p¨âÃè¤ù¬O-1.5D©M+4D¡Aºô½¤ÃèÀ˼vÀ³¸ÓŪ¥X-2.5Dªº©}¥úÈ¡C
(l) ³o22¤ù¸Õ¤ù¥i¥H²Õ¦X¥X-11.5D¦Ü+11.5D¡A¶¡¹j¬°0.5Dªº47ºØ©}¥úÈ¡C
(m) ¦p¦¹¥i¥H±Nºô½¤ÃèÀ˼vªkªº·Ç½T«×ºë¶i¨ì0.5D¡C
(2) ²Ä¤G¨B¡G¬WÃè(´²¥ú)½m²ß
(a) ¨â¤ù¬WÃèÅ|¥[¤@°_¡A²£¥Í¦³²yÃè¤]¦³¬WÃ覨¤Àªº¥ú¾Çµ²ªG¡A¥¦¤£¬O²³æªººâ³N¬Û¥[¡A¤]¤£¬O¦V¶qªº¥[ªk¡A¼Æ¾Ç¤W¥¦¬O¾ò¶ê¡B©ßª«½u¡BÂù¦±½u¨º¼Ëªº¤G¦¸«¬ªºpºâ¡A¤@¯ë¤H¬O¨Sªk¥Ñ¤ßºâ»´©ö±o¨ìµ²ªGªº (¹Ï3-17)¡C
(b) §ÚÌÂǥγo¤@©Ê½è¡A¼g¤F¤@Ó¹q¸£½m²ßµ{¦¡¡A¥Ñ+1D¦Ü+6D¡A©M-1D¦Ü-6D¡A¦@12¤ù¬WÃ褤ÀH·N¿ï¨ú¨â¤ù¡A¸m©ó¼ÒÀÀ²´ªºÃè¼Ñ¤W(¹Ï3-18)¡A½m²ßªÌ§@ºô½¤ÃèÀË¡B¼g¤U©}¥úÈ¡A¤§«á«ö¹q¸£¥ô¤@ÁäÅã¥Üµª®×¡A®Ö¹ïºô½¤ÃèÀ˪ºµ²ªG¡C¾Þ§@¹Lµ{¤¤¨S¦³¥ô¦óªº½u¯Á·t¥Ü¡A¬O¤@ºØÄÇ´I½ì¨ýªº¡BÂùª¼ªº½m²ß¤è¦¡¡C
¹Ï3-17 ¨â¤ù¬WÃèÅ|¥[¤@°_¡A²£¥Í¦³²yÃè¤]¦³¬WÃ覨¤Àªº¥ú¾Çµ²ªG
¹Ï3-18 ¥H¼ÒÀÀ²´½m²ß¬WÃè(´²¥ú)ªººô½¤ÃèÀ˼vªk
(c)¹q¸£µ{¦¡ªºº¶©M»¡©ú¶¡G
¨Ò¤@¡G
¨Ò¤G¡G
µ²§ô¶¡G
3.3 Á{§É½m²ß
§¹¥þ¼ô±x¡B´x´¤¤F¼ÒÀÀ²´¤Wªº½m²ß¤§«á¡A·íµMÁÙ¬O±o¦bªù¶E¯f¤Hªº²´·ú¤W§@³Ì«áªº¾Þ§@»P½m²ß¡C
²Ä4 ¸` ºô½¤ÃèÀ˼vªkªº¤@¨Ç·sÆ[¹î¡B·sµo²{
4.1 ºô½¤ÃèÀ˼vªkªº·sÆ[¹î
¤@¯ë±Ð¬ì®Ñ¤W©Òµeªº¥Ü·N¹Ï¤ñ¨Ò¤£¹ï (¹Ï3-19)¡C
¨¤½¤ª½®|¬ù¬°12mm¡A±aª¬ºô½¤Ã襦æ (parallel)¥ú·½ªº¼e«×¬ù¬°10mm¡A¤£À³¸Ó¹³¹Ï¥Üªº¨º»ò²Ó¡A¦pªG¬Oµo´² (divergent)¥ú·½¡A¦bÁy¤Wªº±aª¬¥úªº¼e«×À³¸Ó§ó¼e¡C
¹Ï3-19 ¤@¯ë±Ð¬ì®Ñ¤W©Òµeªººô½¤ÃèÀ˼vªk¥Ü·N¹Ïªº¤ñ¨Ò¤£¹ï
§Ų́̾ڴX¦ó¥ú¾Ç¡A¦bÓ¤H¹q¸£¤W¼g¤F¤@Óºô½¤ÃèÀ˼vªkªº°ÊºA¼ÒÀÀµ{¦¡¡A¥iÅܰʪº°Ñ¼Æ¦³(1)´ú¸Õ¶ZÂ÷¡A(2)Àû¤Õª½®|¡A(3)¥ú·½µo´²«×(vergence)©M(4)¯f¤Hªº©}¥ú«× (¹Ï3-20)¡C
¹Ï3-20ºô½¤ÃèÀ˼vªkªº¹q¸£°ÊºA¼ÒÀÀµ{¦¡
±aª¬¥ú·½ªº¼e«×©M¨¤½¤ª½®|¡BÀû¤Õª½®|ªº¤ñ¨Ò¬O¨Ì¾Ú¯u¹ê¤Ø¤o¥h´yøªº (¹Ï3-21)¡C¥ª¹Ï¬O¥¦æ¥ú·½¡A¥k¹Ï¬Oµo´²¥ú·½©M¨¤½¤¤j¤pªº¹ê»Ú¤ñ¨Ò¡C
¹Ï3-21 ¥¦æ¥ú·½¡Bµo´²¥ú·½©M¨¤½¤¤j¤pªº¹ê»Ú¤ñ¨Ò
Àû¤Õªº°f°Ê¤Ï¥ú¨Ã¤£·|¥X²{¡§±aª¬¡¨ªº¤Ï¥ú¡C
¤j³¡¤À±Ð¬ì®Ñ¤W´yøªº¶¶°Ê¤Ï¥ú©M°f°Ê¤Ï¥ú³£¬O»á²Óªº ¡¨±aª¬¡¨¤Ï¥ú (¹Ï3-22)¡A¤ñÀû¤Õª½®|²Ó«Ü¦h¡CµM¦Ó¨Æ¹ê¤W¡A°f°Êªº¤Ï¥ú±q¨Ó¤£´¿¨£¹L ¡¨±aª¬¡¨ ªº¤Ï¥ú¡C
¥ý¬Ý¹q¸£¼ÒÀÀ¹Ïªº¶¶°Ê¤Ï¥ú¡C¥¦æ¥ú·½¡A50cmªº´ú¸Õ¶ZÂ÷¡A-0.75D¬O¶¶°Ê¤Ï¥ú (¹Ï3-23)¡C¥Ñ¥ª¦Ó¥k¡B·Q¹³¦¨°ÊºAªºª¬ªp¡A±aª¬¥ú·½¥ÑÀû¤Õ¥ªÃä²¾¤J¡AÀû¤Õ¥ª½t¥ý«G¡A¤Ï¥ú¤]¦P¦V¦a¦V¥k²¾°Ê¡A±aª¬¥ú·½²¾¦ÜÀû¤Õ¤¤½u®É¡AÀû¤Õ¸Ì¬O¤@±ø±aª¬ªº¤Ï¥ú¡C¥ú·½Ä~Äò¦V¥k²¾°Ê¡A¤Ï¥ú¤]¦V¥k²¾°Ê¡A³vº¥±qÀû¤Õ¥k½t²¾¥XÀû¤Õ¡C
¹Ï3-22 ¤@¯ë±Ð¬ì®Ñ¤W´yøªº¶¶°Ê¤Ï¥ú©M°f°Ê¤Ï¥ú³£¬O»á²Óªº¡¨±aª¬¡¨¤Ï¥ú
¹Ï3-23 ¥¦æ¥ú·½¡B50cm´ú¸Õ¶ZÂ÷¡B-0.75D¶¶°Ê¤Ï¥úªº¹q¸£¼ÒÀÀ¹Ï
¥¦æ¥ú·½¡A50cmªº´ú¸Õ¶ZÂ÷¡A-2.75D¬O°f°Ê¤Ï¥ú (¹Ï3-24)¡C¥Ñ¥ª¦Ó¥k¡A±aª¬¥ú·½¥ÑÀû¤Õ¥ª½t²¾¤J¡AÀû¤Õ¬O¥k½t¥ý«G¡A¤Ï¥ú°f¦V¦a¦V¥ª²¾°Ê¡F¥ú·½³vº¥²¾¤JÀû¤Õ¡Aª½¨ìÀû¤Õ¥þ³¡«G°_¨Ó¡A³£¤£´¿¥X²{¹L¡¨±aª¬¡¨ªº¤Ï¥ú¡C¥ú·½Ä~Äò¦V¥k²¾°Ê¡AÅܦ¨Àû¤Õªº¥ª¥bÃ䦳¤Ï¥ú¡A¥ú·½³vº¥¥ÑÀû¤Õ¥k½t²¾¥X¡A³Ì«áªº¤Ï¥ú¬O¥ÑÀû¤Õªº¥ª½t²¾°Ê¥X¥h¡C
¹Ï3-24 ¥¦æ¥ú·½¡B50cm´ú¸Õ¶ZÂ÷¡B-2.75D°f°Ê¤Ï¥úªº¹q¸£¼ÒÀÀ¹Ï
°ÊºAªº±¡ªp¤U¡A¦n¹³¬Ý¨ì¤@±ø¡¨¤ñÀû¤Õ§ó¼eªº±aª¬¤Ï¥ú¡¨¥Ñ¥k¦V¥ª²¾°Ê¡A¥ÑÀû¤Õ¥k½t²¾¶iÀû¤Õ¡A¤§«á¥ÑÀû¤Õ¥ª½t²¾¥XÀû¤Õ¡CµM¦Ó¦b¥ô¦ó¤@Àþ¶¡¡A§A³»¦h¥u¬Ý¨ì¤Ï¥úªº¥ª½t©Î¥k½t¡Aµ´¨S¦³¦P®É¬Ý¨ì¤Ï¥úªº¨âÓÃä½t¡C´«¥y¸Ü»¡¡A¨Ã¨S¦³¦bÀû¤Õ¸Ì¨£¨ì¯u¥¿ªº¡¨±aª¬¡¨¤Ï¥ú¡C
AAO BCSC Clinical Optics¤@®Ñ¸Ìªººô½¤ÃèÀ˼vªk¡A¤§«eÀû¤Õªº°f°Ê¤Ï¥ú¤]¬O´yø¦¨¡¨±aª¬¡¨ªº¤Ï¥ú¡A2014-2015ªº·sª©¥»¸Ì¡AChapter 3 Clinical Refraction P.95¡A¤w¸g§ó¥¿¬°Àû¤Õ¤Ï¥ú¥u¯à¬Ý¨£³æ¤@¤Ï¥úÃä½tªº¹Ï¼Ë¤F(¹Ï3-25)¡C
¹Ï3-25 AAO±Ð¬ì®Ñ¤WÀû¤Õªº°f°Ê¤Ï¥ú¤w¸g§ó¥¿¬°¥u¯à¬Ý¨£³æ¤@ªº¤Ï¥úÃä½t
4.2 ºô½¤ÃèÀ˼vªkªº·sµo²{
µø¥ú¾Ç±Ð¬ì®Ñ¸Ìºô½¤ÃèÀ˼vªkªº¥ú¾Çì²z³£¼g¨ì¡¨¯f¤Hªº»·ÂI¸¨¦b¯f¤H©MÀˬdªÌ¤§¶¡®É¡AÀû¤Õ©Ò¨£¬O°f°Ê¤Ï¥ú¡¨¡C¦b§C«×ªñµø¡A¨Ò¦p-2.75D¡AªºÀû¤Õ¤Ï¥ú½T¹ê¬O¦p¦¹¡C¦ý¬O±q¹q¸£¼ÒÀÀ¹Ï¥h¬Ý§ó°ª«×ªºªñµøªºÀû¤Õ¤Ï¥ú¡Aµo²{¨Æ¹ê¨Ã¤£³o»ò²³æ¡A¨Ã¤£³£¬O°f°Êªº¤Ï¥ú¡C
¤¤«×ªñµøªºÀû¤Õ¤Ï¥ú¬O¡¨Ãþ°f°Ê¤Ï¥ú¡¨ (apparent
against-movement)
¹Ï¥Üªñµø-3.75D¡A¥H¥¦æ¥ú·½¦b50¤½¤À§@ºô½¤ÃèÀ˼v¡C¥Ñ¥ª¦Ó¥k¡A±aª¬¥ú·½¥ÑÀû¤Õ¥ª½t²¾¤J¡A¨Ã¤£¬OÀû¤ÕªºÃä½t¥ý«G¡A¦Ó¬O¦bÀû¤Õ¸ÌÃä¡B°¾¥kªº¤@Ó¦a¤è¥ý«G°_¨Ó¡C¥ú·½²¾¤JÀû¤Õ¡A¤Ï¥úÅܼe¡A«Ü§Ö´NIJ¸I¨ìÀû¤Õªº¥k½t¡C¤§«áÀû¤Õ¸Ì¥u¯à¬Ý¨ì¤Ï¥úªº¥ª½t¦V¥ª²¾°Ê¡A¬Ý°_¨Ó«Ü¹³¬O°f°Êªº¤Ï¥ú¡A§Ú̺٤§¬°¡¨Ãþ°f°Ê¤Ï¥ú¡¨¡C (¹Ï3-26)
¹Ï3-26¤¤«×ªñµøªºÀû¤Õ¤Ï¥ú¬O¡¨Ãþ°f°Ê¤Ï¥ú¡¨
°ª«×ªñµøªºÀû¤Õ¤Ï¥ú¬O¡§Ãþ¶¶°Ê¤Ï¥ú¡¨
(apparent with-movement)
¹Ï¥Üªñµø - 6.75D¡A±aª¬¥ú·½¥ÑÀû¤Õ¥ª½t²¾¤J¡A¬OÀû¤Õ¸ÌÃä¡B°¾¥ªªº¤@Ó¦a¤è¥ý«G°_¨Ó¡C¥ú·½²¾¤JÀû¤Õ¡A¤Ï¥úÅܼe¡A«Ü§Ö´NIJ¸I¨ìÀû¤Õªº¥ª½t¡C¤§«áÀû¤Õ¸Ì¥u¯à§Ü¬Ý¨ì¤Ï¥úªº¥k½t¦V¥k²¾°Ê¡A¬Ý°_¨Ó«Ü¹³¬O¶¶°Êªº¤Ï¥ú¡A§Ú̺٤§¬°¡¨Ãþ¶¶°Ê¤Ï¥ú¡¨¡C (¹Ï3-27)
¹Ï3-27°ª«×ªñµøªºÀû¤Õ¤Ï¥ú¬O¡§Ãþ¶¶°Ê¤Ï¥ú¡¨
¥Ñ¤¤«×ªñµøº¥º¥¥[²`¨ì°ª«×ªñµø¡A¥ÑÃþ°f°Ê¤Ï¥úº¥º¥Åܦ¨Ãþ¶¶°Ê¤Ï¥úªº¹Lµ{¸Ì¡A¤j¬ù¦b - 4.5D¥ª¥k¡A·í¥ú·½¥ÑÀû¤ÕÃä½t¶i¤JÀû¤Õªº®ÉÔ¡AÀû¤Õ¤Ï¥ú¬O¥ÑÀû¤Õ¥¿¤¤¥¡ªº¦a¤è²v¥ý«G°_¨Ó¡I
4.3 ºô½¤ÃèÀ˼vªkªº·sÆ[©À
¥Ñ¥H¤Wªºµo²{§Ú̪¾¹D¡A¦b§@ºô½¤ÃèÀ˼vªkªº®ÉÔ¡A²Ä¤@²´¬Ý¨ì·tªº¶¶°Ê¤Ï¥ú¡A¤£n¥ß¨è»{¬°³o¬O°ª«×»·µø¡A¥¦¤]¦³¥i¯à¬O°ª«×ªñµøªºÃþ¶¶°Ê¤Ï¥ú¡C·íµM³o°ÝÃD«Ü®e©ö¸Ñ¨M¡A§A¥un¥[¤WÓtÃè (~-4D)©Î¥¿Ãè (~+4D)§@«Å|Åç¥ú¡A¥ß¨è¥i¥H¤À¿ë¥X¨Ó¯f¤H¨ì©³¬O°ª«×»·µø²´©ÎªÌ¬O°ª«×ªñµø²´¡C
·íµM¡A§Ú̪º³oÓ·sµo²{¨Ã¤£¼vÅT쥻ºô½¤ÃèÀ˼vªkªº¤¤©MÂI (neutral point)ªº§PŪ¡C
¦pªG¥H¤º»E¥ú·½§@ºô½¤ÃèÀ˼v¡AÀû¤Õ¤Ï¥úªº¶¶°Ê¡B°f°Ê©M¨Ï¥Îµo´²/¥¦æ¥ú·½ªºÀû¤Õ¤Ï¥ú³£¬Û¤Ï¡C¥Î¤º»E¥ú·½§@ºô½¤ÃèÀ˼vªkªº¸Ü¡A§Ú̪º·sÆ[¹î¡B·sµo²{¤S§e²{«ç¼Ëªº±»ª©O¡H(1)¤º»E¥ú·½ªº°f°Ê¤Ï¥ú¦P¼Ë¤£·|¥X²{ ¡¨±aª¬¡¨ªº¤Ï¥ú¡F(2) ¡¨»·µø²´¡¨³vº¥¥[²`ªº®ÉÔ¡AÀû¤Õ¤Ï¥úªºÅܤơA¤]¬O¥Ñ°f°Ê¤Ï¥ú³vº¥Åܦ¨ ¡¨Ãþ°f°Ê¤Ï¥ú¡¨¡A¦A³vº¥Åܦ¨ ¡¨Ãþ¶¶°Ê¤Ï¥ú¡¨¡C
[«á°O:·P·Q] ¤£ª¾¹D¬O¤°»ò¼Ëªº¦]¯À¡A·Qn¾Ç²ß¡B·Q¥h¼ô±x¥H¤Î·|¥h¾Þ½mºô½¤ÃèÀ˼vªkªº²´¬ìÂå®v©MÅç¥ú®v«D±`¤§¤Ö¡C¤å¨}«ÛÂå®v§i¶D§Ú¡A¥L¥H«e´¿¸g°Ñ¥[¹Lºô½¤ÃèÀ˼vªk¯ª®v·ÝJack Copelandªº±aª¬ºô½¤ÃèÀ˼vªk (streak retinoscopy) ªº¬ã²ßÀç¡C§Ú«Øij²´¬ì¾Ç·|¿ìÓ¬ã²ßÀç¡AWet Lab or Dry Lab¡A·Ç³Æ20²Õºô½¤Ãè¡B¼Ò«¬²´©MÃè¤ù²Õ¡A©w´ÁÁ|¿ì¬ã²ß¡A´°«P¤j®a¥h¾Ç²ß³oÓ«D±`¦³¥Î¡A«o¤w¸g®õ¥b¥¢¶ÇªºÁ{§É¤u¨ã¡C
«ØijŪª«¤Î°Ñ¦Ò¤åÄm
1. Wang AH. Self-assessment
of retinoscopy and other objective refraction. Presented at 18th Congress of the
ÂÔ¥H¥»¤åÄmµ¹
The Smith-Kettlewell Eye Research
Institute (SKERI)ªº¦Ñ®vÌ
Dr. Arthur Jampolsky
Dr. Alan Scott
Dr. Anthony Norcia
Dr. Eric Sutter
Dr. Christopher Tyler
ªø°O±o1990-1991 ¦aÆF¤H³ÇªºÂª÷¤s ¤p¨à²´¬ìfellowshipªº¤@¦~
§@ªÌ ¤ýħ«J
¾Ç¾ú¡G ¥xÆW¤j¾Ç Âå¾Ç¤h
¥xÆW¤j¾Ç Á{§ÉÂå¾Ç³Õ¤h
¬ü°êª÷¤sThe Smith-Kettlewell Eye Research
Institute (SKERI)º[Pacific
Presbyterian Medical Center ¤p¨à²´¬ìº[±×µø¬ã¨sû
¸g¾ú¡G ¥x¤jÂå°| ²´¬ì ¦í°|Âå®v ¥DªvÂå®v
¥x¤jÂå¾Ç°| ²´¬ì °Æ±Ð±Â
²{¾¡G °ê®õÂå°| ²´¬ì
¤j¾Ç²´¬ì ¥DªvÂå®v